These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1900073)

  • 1. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential.
    Naotunne TS; Karunaweera ND; Del Giudice G; Kularatne MU; Grau GE; Carter R; Mendis KN
    J Exp Med; 1991 Mar; 173(3):523-9. PubMed ID: 1900073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-parasite effects of cytokines in malaria.
    Mendis KN; Naotunne TD; Karunaweera ND; Del Giudice G; Grau GE; Carter R
    Immunol Lett; 1990 Aug; 25(1-3):217-20. PubMed ID: 2126526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica.
    Naotunne TD; Rathnayake KD; Jayasinghe A; Carter R; Mendis KN
    Exp Parasitol; 1990 Oct; 71(3):305-13. PubMed ID: 2209788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.
    Clark IA; Hunt NH; Butcher GA; Cowden WB
    J Immunol; 1987 Nov; 139(10):3493-6. PubMed ID: 3119710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages.
    Ockenhouse CF; Schulman S; Shear HL
    J Immunol; 1984 Sep; 133(3):1601-8. PubMed ID: 6431003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients.
    Karunaweera ND; Carter R; Grau GE; Kwiatkowski D; Del Giudice G; Mendis KN
    Clin Exp Immunol; 1992 Jun; 88(3):499-505. PubMed ID: 1351432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of the infectivity of Plasmodium gametocytes by the serum of the parasite host. Perfecting an experimental model].
    Bastien P; Landau I; Baccam D
    Ann Parasitol Hum Comp; 1987; 62(3):195-208. PubMed ID: 3662325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphology and infectivity of gametocytes of Plasmodium inui].
    Dei-Cas E; Maurois P; Landau I; Dutoit E; Miltgen F; Vernes A; Biguet J
    Ann Parasitol Hum Comp; 1980; 55(6):621-33. PubMed ID: 7469303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of acute malaria (Plasmodium berghei in the rat): reversibility and spleen dependence.
    Quinn TC; Wyler DJ
    Am J Trop Med Hyg; 1980 Jan; 29(1):1-4. PubMed ID: 6986095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparasitic effects of tumour necrosis factor in vivo and in vitro.
    Playfair JH; Taverne J
    Ciba Found Symp; 1987; 131():192-205. PubMed ID: 3131074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.
    Taverne J; Tavernier J; Fiers W; Playfair JH
    Clin Exp Immunol; 1987 Jan; 67(1):1-4. PubMed ID: 3621669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice.
    Kumaratilake LM; Rathjen DA; Mack P; Widmer F; Prasertsiriroj V; Ferrante A
    J Clin Invest; 1995 May; 95(5):2315-23. PubMed ID: 7738194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic variation of cloned Plasmodium fragile in its natural host Macaca sinica. Sequential appearance of successive variant antigenic types.
    Handunnetti SM; Mendis KN; David PH
    J Exp Med; 1987 May; 165(5):1269-83. PubMed ID: 3553414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor and associated cytokines in the host's response to malaria.
    Richards AL
    Int J Parasitol; 1997 Oct; 27(10):1251-63. PubMed ID: 9394195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model of Plasmodium vivax concealment based on Plasmodium cynomolgi infections in Macaca mulatta.
    Fonseca LL; Joyner CJ; ; Galinski MR; Voit EO
    Malar J; 2017 Sep; 16(1):375. PubMed ID: 28923058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor does not induce Plasmodium falciparum crisis forms.
    Jensen JB; Vande Waa JA; Karadsheh AJ
    Infect Immun; 1987 Jul; 55(7):1722-4. PubMed ID: 3298067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine production in rhesus monkeys infected with Plasmodium coatneyi.
    Yang C; Xiao L; Tongren JE; Sullivan J; Lal AA; Collins WE
    Am J Trop Med Hyg; 1999 Aug; 61(2):226-9. PubMed ID: 10463671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterile protection of monkeys against malaria after administration of interleukin-12.
    Hoffman SL; Crutcher JM; Puri SK; Ansari AA; Villinger F; Franke ED; Singh PP; Finkelman F; Gately MK; Dutta GP; Sedegah M
    Nat Med; 1997 Jan; 3(1):80-3. PubMed ID: 8986746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria.
    Hemmer CJ; Holst FG; Kern P; Chiwakata CB; Dietrich M; Reisinger EC
    Trop Med Int Health; 2006 Jun; 11(6):817-23. PubMed ID: 16772003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.